Tom,
Give Dr. H a call and start getting him involved in conferences like this one!
Tuesday May 20 7:01 AM EDT
Company Press Release
Source: Cruttenden Roth
Healthcare Firms to Court Investors at Today's Cruttenden Roth Conference; Former FDA Commissioner Featured
NEW YORK, May 20 /PRNewswire/ -- What new medical technologies, services and pharmaceuticals are on the research tables of some of our nation's healthcare companies?
Find out at the Cruttenden Roth Healthcare Conference, which continues today, May 20 at the St. Regis Hotel in New York City, where emerging growth companies in the biomed, medical devices and products, pharmaceuticals, dental, and healthcare industries will be offering insight.
Featured speaker at this year's conference is former FDA Commissioner Dr. David A. Kessler, who will be addressing the 500-plus attendees at today's luncheon in the 20th Floor Ballroom of the St. Regis. Until this past March, Dr. Kessler served as FDA Commissioner for seven years under both the Bush and Clinton Administrations. On July 1st he will become Dean of the Yale University School of Medicine.
The goal of the 73 public and nine private presenting companies at this two-day event, is to capture the interests of the nation's institutional investors and portfolio managers; the kind of interest that can infuse additional capital needed for continued research and development of new medical products and services.
Cruttenden Roth, a Western US-based underwriter specializing in emerging growth companies, sponsors this conference to provide ``small cap healthcare companies an opportunity to meet one-on-one with some of the most influential investors and analysts on Wall Street,'' said Byron Roth, President of Cruttenden Roth.
During the two-day event, top management from each company will be allocated a 20-minute segment to present their company stories. Presentations will be followed by breakout sessions for public companies where investors will get face time with each company's management, and receive hands-on demonstrations of the company's products and services.
Co-sponsors of this year's conference include Stradling Yocca Carlson & Rauth, a leading Western US law firm; Arthur Andersen, the multidisciplinary professional services firm; PR Newswire, the international press relations service; and RR Donnelly, financial publishers. Institutional investors, financial advisors, analysts and portfolio managers will be hosted. For registration information contact Cruttenden Roth's conference desk: (714) 757-5786.
Cruttenden Roth is a regional investment bank and brokerage specializing in emerging growth companies. One of the most active regional underwriters in the west, the firm has won recognition as one of the best performing underwriters in the nation, based on aftermarket performance. Headquartered in Irvine, California, the Company maintains regional offices in Los Angeles, Santa Barbara, Sam Francisco, Seattle and Denver. It is a member of the National Association of Securities Dealers (NASD), the Securities Industry Association (SIA), and the Securities Investor Protection Corporation (SIPC). Arrangements for the appearance of David Kessler made through Greater Talent Network Inc., New York, NY.
PRESENTING PUBLIC COMPANIES INCLUDE:
AccuMed International, Inc. (ACMI) LifeCell Corporation (LIFC)
Aksys, Ltd. (AKSY) Matria Healthcare, Inc. (MATR)
Alkermes, Inc. (ALKS) Matritech, Inc. (NMPS)
Alliance Pharmaceutical Corp. (ALLP) Medical Asset Management, Inc. (MAMT)
Anika Therapeutics, Inc. (ANIK) Medstone International, Inc. (MEDS)
Atrix Laboratories, Inc. (ATRX) Neoprobe Corporation (NEOP)
Biomatrix, Inc. (BIOX) Norland Medical Systems, Inc. (NRLD)
BioSource International, Inc. (BIOI) Organogenesis, Inc. (ORG)
Boston Biomedica Inc. (BBII)
Cambridge NeuroScience, Inc. (CNSI) Patient Infosystems, Inc. (PATI)
CollaGenex Pharmaceuticals, Inc. (CGPI) PerSeptive Biosystems, Inc. (PBIO)
CompDent Corporation (CPDN) PharmaPrint Inc. (PPRT)
Conceptus, Inc. (CPTS) Physician Support Systems,
Inc.(PHSS)
Cypros Pharmaceutical Corporation (CYPR)
Diametrics Medical, Inc. (DMED) Physiometrix, Inc. (PHYX)
Draxis Health Inc. (DRAXF) PLC Systems, Inc. (PLC)
DUSA Pharmaceuticals, Inc. (DUSA) PolyMedica Industries, Inc. (PM)
Eclipse Medical Technologies, Inc. (ESTI) QuadraMed Corporation (QMDC)
ENDOcare, Inc. (ENDO) Quality Systems, Inc. (QSII)
Endovascular Technologies, Inc. (EVTI) Quantech Ltd. (QQQQ)
Erox Corporation (EROX)
Exactech, Inc. (EXAC) Rockford Industries, Inc. (ROCF)
First Commonwealth, Inc. (FCWI) RoTech Medical Corporation (ROTC)
GranCare, Inc. (GC) Sabratek Corporation (SBTK)
Hanger Orthopedic Group, Inc. (HGR) Safeguard Health Enterprises, Inc.
(SFGD)
Hemagen Diagnostics, Inc. (HMGN) Sheridan HealthCare, Inc. (SHCR)
Hooper Holmes, Inc. (HH) Techniclone Corporation (TCLN)
HumaScan Inc. (HMSC) Texas Biotechnology Corporation (TXB)
ID Biomedical Corporation (IDBEF) Thoratec Laboratories Corporation
(THOR)
Image Guided Technology, Inc. (IGTI) Trimedyne, Inc. (TMED)
Ultrafem, Inc. (UFEM)
Imatron Inc. (IMAT) Unimed Pharmaceuticals, Inc. (UMED)
The Immune Response Corporation (IMNR) United Dental Care, Inc. (UDCI)
IMNET Systems, Inc. (IMNT) UROHEALTH Systems, Inc. (UROH)
InnerDyne, Inc. (IDYN)
Integrated Medical Resources, Inc. (IMRI)
Interpore International (BONZ) Voxel (VOXL)
KV Pharmaceutical Company (KV.A/KV.B) Xenometrix, Inc. (XENO)
Laserscope (LSCP) Zonagen, Inc. (ZONA)
PRESENTING PRIVATE COMPANIES INCLUDE:
BioStar, Inc. Norian Corporation
Energy Life Systems Corporation OraPharma, Inc.
IntraVascular Medical, Inc. PrISMedical Corporation
Laurus Medical Corporation RayMedica, Inc.
NeoVision Corporation |
